TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
CompletedEARLY_Phase 1

TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease

Gait and balance problems are a significant source of disability in patients with Parkinson disease. Physical therapy remains one of the main treatments.

Cleveland, Ohio, United StatesView details
UnknownN/A

Action Observation Theraphy in Parkinson's Disease

The main objective of this project is to evaluate the effectiveness of Observation of Action (Action Observation, AO) both in increasing the speed of movement of the upper limbs, agility and locomotion, and in improving the activities and q

Venezia, ItalyView details
RecruitingN/A

The Effect of Spinal Mobilization on Respiratory Parameters in Parkinson's Disease Patients

Parkinson's patients suffer from respiratory distress for different reasons. It is thought that physiotherapy methods that have an indirect effect on the diaphragm can improve respiratory functions.

Bolu, Turkey (Türkiye)+1 moreView details
UnknownN/A

Sensory Cues for Freezing in Parkinson's Disease

The purpose of this study is (1) to determine if patient triggered sensory(auditory, visual and tactile) cues can help treat freezing of gait in Parkinson's disease, and (2) to assess if unexpected (randomized) cues are more effective than

Melbourne, Victoria, AustraliaView details
TerminatedPhase 3

A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.

This study is a Phase III, multicentre, randomized, initial double-blind study with subsequent open label phases. The study will havea screening phase (4 weeks), a dose increase effect verification phase (12 weeks), a down titration 1 phase

Aichi, Japan+16 moreView details
Not yet recruiting

AI-PROGNOSIS - Digital Biomarkers Development Study (dBM-DEV)

dBM-dev study is a multicentre low-intervention research study which concerns REM sleep behaviour disorder (RBD) who is the best predictor for neurodegenerative diseases including Parkinson's disease (PD). RBD can only be confirmed by polys

Toulouse, France+3 moreView details
CompletedN/A

Whey Protein Supplementation in Patients With Parkinson's Disease

Many dietary supplementations are available to help people in balancing the protein intake and overcoming muscle mass loss. However, most of the products contain protein and could potentially affect levodopa action in people with Parkinson'

Gravedona, Como, ItalyView details
UnknownN/A

Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

The aim of this pilot study is to investigate the effect of Osteopathic Manipulative Medicine (OMM) in decreasing constipation symptoms in people with Parkinson's disease (PD). A second but optional aim is to determine if OMM changes the ba

Old Westbury, New York, United StatesView details
UnknownN/A

Outcomes to the Nutritional Need of Patients With Parkinson's Disease

The intervention involves the identification of 140 patients (70 per group), fed throughout the duration of the study with the two different solutions indicated. The subject will be interviewed by identified and trained personnel in order t

Genova, ItalyView details
CompletedPhase 4

Istradefylline Effect Protocol on Parkinson's Disease Tremor

This is an investigator-initiated trial. In this 6-month open label, single arm, exploratory pilot study, the investigator intends to enroll a pilot sample of 25 patients with Parkinson's disease who are being started on the novel FDA appro

McLean, Virginia, United StatesView details
RecruitingN/A

Exercise Neuroprotection in Parkinson's Disease

The purpose of this study is to explore the relationships of exercise on inflammation in the body of older adults and people with Parkinson's disease (PD). This is important research for older adults but is especially important for people w

Las Vegas, Nevada, United StatesView details
Completed

Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.

In this investigator-initiated study, we will compare changes in brain cognitive biomarkers assessed by diffusion tensor imaging over 2.5 years among 12 patients with Idiopathic Parkinson's disease (IPD) receiving rasagiline, 20 IPD patient

Buffalo, New York, United StatesView details
CompletedN/A

Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD)

Bilateral subthalamic nucleus deep brain stimulation (B-STN DBS) is one of the most effective surgical treatments for PD patients suffering from levodopa-induced motor complications. The relatively low incidence of permanent adverse effects

Multiple locationsView details
Not yet recruitingPhase 1

Clinical Research on Stem Cell Therapy for Parkinson's Disease

This study, through different administration methods, adopted a randomized, double-blind, placebo-controlled trial design to evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells (hUC-MSCs) in patients with Par

Multiple locationsView details
RecruitingN/A

Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands

The goal of this clinical trial is to investigate the feasibility if a remotely administered smartphone app can increase the volume and intensity of physical activity in daily life in patients with isolated Rapid Eye Movement (REM) sleep be

Nijmegen, Gelderland, NetherlandsView details
CompletedPhase 3

Brain Fitness in Parkinson's Disease

The purpose of this study is to examine the feasibility and potential effectiveness of a cognitive training program among persons with Parkinson's disease. It is hypothesized that individuals with PD will be able to complete and benefit fro

Tampa, Florida, United StatesView details
CompletedPhase 1

Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease

Investigators will evaluate the safety of a 48 week regimen of Leukine administered as a weight-based dose at 3 ug/kg/ day for 5 days followed by a 2-day holiday. This 48 week long study will extend the prior biomarker evaluations observed

Omaha, Nebraska, United StatesView details
Recruiting

Pesticides and Parkinson´s Disease

The aim of this project is to study whether people exposed to pesticides have a higher risk of developing PD. We will perform an epidemiological study determining the presence of pesticides in urine and comparing signs traditionally associa

Burgos, SpainView details
CompletedPhase 1

Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients

The study will evaluate the safety and tolerability of ACR325 in Parkinson disease patients and evaluate the effect on levodopa induced dyskinesias.

Kassel, Hesse, Germany+1 moreView details
CompletedPhase 1

Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

The purpose of this study is to investigate the tolerability and safety of three multiple dose regimens of nebicapone (BIA 3-202 100 mg, 200 mg, and 300 mg 6 times daily) in healthy volunteers. To characterise the steady-state pharmacokinet

S. Mamede Do Coronado, S. Mamede Do Coronado, PortugalView details
Load more trials